HEADER HYDROLASE 13-JUN-07 2Q9M TITLE 4-SUBSTITUTED TRINEMS AS BROAD SPECTRUM-LACTAMASE INHIBITORS: TITLE 2 STRUCTURE-BASED DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CEPHALOSPORINASE; COMPND 5 EC: 3.5.2.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTER CLOACAE; SOURCE 3 ORGANISM_TAXID: 550; SOURCE 4 STRAIN: 908R KEYWDS BETA-LACTAMASE INHIBITOR, TRICYCLIC CARBAPENEM, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR I.PLANTAN,L.SELIC,T.MESAR,P.STEFANIC ANDERLUH,M.OBLAK,A.PREZELJ, AUTHOR 2 L.HESSE,M.ANDREJASIC,M.VILAR,D.TURK,A.KOCIJAN,T.PREVEC,G.VILFAN, AUTHOR 3 D.KOCJAN,A.COPAR,U.URLEB,T.SOLMAJER REVDAT 6 20-NOV-24 2Q9M 1 REMARK REVDAT 5 30-AUG-23 2Q9M 1 REMARK LINK REVDAT 4 31-MAR-09 2Q9M 1 REMARK REVDAT 3 24-FEB-09 2Q9M 1 VERSN REVDAT 2 28-AUG-07 2Q9M 1 JRNL REVDAT 1 21-AUG-07 2Q9M 0 JRNL AUTH I.PLANTAN,L.SELIC,T.MESAR,P.S.ANDERLUH,M.OBLAK,A.PREZELJ, JRNL AUTH 2 L.HESSE,M.ANDREJASIC,M.VILAR,D.TURK,A.KOCIJAN,T.PREVEC, JRNL AUTH 3 G.VILFAN,D.KOCJAN,A.COPAR,U.URLEB,T.SOLMAJER JRNL TITL 4-SUBSTITUTED TRINEMS AS BROAD SPECTRUM BETA-LACTAMASE JRNL TITL 2 INHIBITORS: STRUCTURE-BASED DESIGN, SYNTHESIS, AND JRNL TITL 3 BIOLOGICAL ACTIVITY JRNL REF J.MED.CHEM. V. 50 4113 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17665896 JRNL DOI 10.1021/JM0703237 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : MAIN REMARK 3 AUTHORS : TURK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 21206 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1060 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2751 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 368 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.686 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q9M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000043322. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAY-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL (SI111, SI220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21206 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1XX2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M CACODYLATE, 30% PEG8000, PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 38.32600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.88800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.32600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.88800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 PRO A 2 CG CD REMARK 480 GLU A 5 CD OE1 OE2 REMARK 480 ASN A 14 OD1 ND2 REMARK 480 LYS A 21 CG CD CE NZ REMARK 480 LYS A 37 CG CD CE NZ REMARK 480 ILE A 48 CG1 CG2 CD1 REMARK 480 ARG A 133 CG CD NE CZ NH1 NH2 REMARK 480 ASN A 137 ND2 REMARK 480 GLN A 139 CG CD OE1 NE2 REMARK 480 LYS A 143 NZ REMARK 480 LYS A 207 CE NZ REMARK 480 SER A 212 OG REMARK 480 LYS A 249 NZ REMARK 480 VAL A 278 CG1 CG2 REMARK 480 GLU A 279 OE1 OE2 REMARK 480 ASN A 281 OD1 ND2 REMARK 480 LYS A 290 CB CG CD CE NZ REMARK 480 LYS A 309 CG CD CE NZ REMARK 480 LYS A 332 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 705 O HOH A 727 0.48 REMARK 500 OG SER A 64 O1 LK7 A 0 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 717 O HOH A 728 3556 0.25 REMARK 500 O HOH A 603 O HOH A 718 1554 0.32 REMARK 500 O HOH A 702 O HOH A 721 3556 0.82 REMARK 500 CD PRO A 2 O HOH A 631 3545 1.78 REMARK 500 O HOH A 476 O HOH A 559 3556 1.84 REMARK 500 OD2 ASP A 205 O HOH A 721 3556 2.09 REMARK 500 O HOH A 591 O HOH A 642 3546 2.12 REMARK 500 O HOH A 363 O HOH A 634 3545 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 177 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG A 177 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 154 -70.15 -82.96 REMARK 500 VAL A 178 -58.17 -122.86 REMARK 500 ARG A 204 -85.80 -95.11 REMARK 500 TYR A 221 18.33 -159.07 REMARK 500 LYS A 315 129.18 -174.49 REMARK 500 ASN A 341 43.35 -93.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 716 REMARK 615 HOH A 720 REMARK 615 HOH A 726 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LK7 A 0 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XX2 RELATED DB: PDB DBREF 2Q9M A 2 360 UNP P05364 AMPC_ENTCL 22 380 SEQRES 1 A 359 PRO VAL SER GLU LYS GLN LEU ALA GLU VAL VAL ALA ASN SEQRES 2 A 359 THR ILE THR PRO LEU MET LYS ALA GLN SER VAL PRO GLY SEQRES 3 A 359 MET ALA VAL ALA VAL ILE TYR GLN GLY LYS PRO HIS TYR SEQRES 4 A 359 TYR THR PHE GLY LYS ALA ASP ILE ALA ALA ASN LYS PRO SEQRES 5 A 359 VAL THR PRO GLN THR LEU PHE GLU LEU GLY SER ILE SER SEQRES 6 A 359 LYS THR PHE THR GLY VAL LEU GLY GLY ASP ALA ILE ALA SEQRES 7 A 359 ARG GLY GLU ILE SER LEU ASP ASP ALA VAL THR ARG TYR SEQRES 8 A 359 TRP PRO GLN LEU THR GLY LYS GLN TRP GLN GLY ILE ARG SEQRES 9 A 359 MET LEU ASP LEU ALA THR TYR THR ALA GLY GLY LEU PRO SEQRES 10 A 359 LEU GLN VAL PRO ASP GLU VAL THR ASP ASN ALA SER LEU SEQRES 11 A 359 LEU ARG PHE TYR GLN ASN TRP GLN PRO GLN TRP LYS PRO SEQRES 12 A 359 GLY THR THR ARG LEU TYR ALA ASN ALA SER ILE GLY LEU SEQRES 13 A 359 PHE GLY ALA LEU ALA VAL LYS PRO SER GLY MET PRO TYR SEQRES 14 A 359 GLU GLN ALA MET THR THR ARG VAL LEU LYS PRO LEU LYS SEQRES 15 A 359 LEU ASP HIS THR TRP ILE ASN VAL PRO LYS ALA GLU GLU SEQRES 16 A 359 ALA HIS TYR ALA TRP GLY TYR ARG ASP GLY LYS ALA VAL SEQRES 17 A 359 ARG VAL SER PRO GLY MET LEU ASP ALA GLN ALA TYR GLY SEQRES 18 A 359 VAL LYS THR ASN VAL GLN ASP MET ALA ASN TRP VAL MET SEQRES 19 A 359 ALA ASN MET ALA PRO GLU ASN VAL ALA ASP ALA SER LEU SEQRES 20 A 359 LYS GLN GLY ILE ALA LEU ALA GLN SER ARG TYR TRP ARG SEQRES 21 A 359 ILE GLY SER MET TYR GLN GLY LEU GLY TRP GLU MET LEU SEQRES 22 A 359 ASN TRP PRO VAL GLU ALA ASN THR VAL VAL GLU GLY SER SEQRES 23 A 359 ASP SER LYS VAL ALA LEU ALA PRO LEU PRO VAL ALA GLU SEQRES 24 A 359 VAL ASN PRO PRO ALA PRO PRO VAL LYS ALA SER TRP VAL SEQRES 25 A 359 HIS LYS THR GLY SER THR GLY GLY PHE GLY SER TYR VAL SEQRES 26 A 359 ALA PHE ILE PRO GLU LYS GLN ILE GLY ILE VAL MET LEU SEQRES 27 A 359 ALA ASN THR SER TYR PRO ASN PRO ALA ARG VAL GLU ALA SEQRES 28 A 359 ALA TYR HIS ILE LEU GLU ALA LEU HET LK7 A 0 19 HETNAM LK7 (1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5, HETNAM 2 LK7 6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID FORMUL 2 LK7 C14 H19 N O4 FORMUL 3 HOH *368(H2 O) HELIX 1 1 SER A 4 SER A 24 1 21 HELIX 2 2 ILE A 65 ARG A 80 1 16 HELIX 3 3 ALA A 88 TRP A 93 5 6 HELIX 4 4 GLY A 98 GLN A 102 5 5 HELIX 5 5 ARG A 105 TYR A 112 1 8 HELIX 6 6 ASP A 127 TRP A 138 1 12 HELIX 7 7 ALA A 151 VAL A 163 1 13 HELIX 8 8 LYS A 164 GLY A 167 5 4 HELIX 9 9 PRO A 169 VAL A 178 1 10 HELIX 10 10 PRO A 192 TYR A 199 5 8 HELIX 11 11 LEU A 216 TYR A 221 1 6 HELIX 12 12 ASN A 226 ALA A 239 1 14 HELIX 13 13 PRO A 240 VAL A 243 5 4 HELIX 14 14 ASP A 245 GLN A 256 1 12 HELIX 15 15 GLU A 279 GLY A 286 1 8 HELIX 16 16 ASP A 288 LEU A 293 1 6 HELIX 17 17 PRO A 330 LYS A 332 5 3 HELIX 18 18 PRO A 345 LEU A 360 1 16 SHEET 1 A10 LYS A 52 PRO A 53 0 SHEET 2 A10 LYS A 37 ASP A 47 -1 N ALA A 46 O LYS A 52 SHEET 3 A10 GLY A 27 TYR A 34 -1 N VAL A 30 O TYR A 41 SHEET 4 A10 ILE A 334 ALA A 340 -1 O LEU A 339 N ALA A 29 SHEET 5 A10 GLY A 323 PHE A 328 -1 N TYR A 325 O MET A 338 SHEET 6 A10 SER A 311 SER A 318 -1 N VAL A 313 O PHE A 328 SHEET 7 A10 GLU A 272 ASN A 275 -1 N LEU A 274 O TRP A 312 SHEET 8 A10 MET A 265 GLN A 267 -1 N TYR A 266 O MET A 273 SHEET 9 A10 ARG A 258 ILE A 262 -1 N ILE A 262 O MET A 265 SHEET 10 A10 ALA A 299 ALA A 305 -1 O ALA A 305 N ARG A 258 SHEET 1 B 2 PHE A 60 GLU A 61 0 SHEET 2 B 2 LYS A 224 THR A 225 -1 O THR A 225 N PHE A 60 SHEET 1 C 2 THR A 147 ARG A 148 0 SHEET 2 C 2 LEU A 296 PRO A 297 -1 O LEU A 296 N ARG A 148 SHEET 1 D 2 GLY A 202 TYR A 203 0 SHEET 2 D 2 ALA A 208 VAL A 209 -1 O VAL A 209 N GLY A 202 LINK C4 LK7 A 0 OG SER A 64 1555 1555 1.31 CISPEP 1 TRP A 276 PRO A 277 0 0.17 CISPEP 2 ASN A 302 PRO A 303 0 0.00 SITE 1 AC1 10 SER A 64 TYR A 150 ASN A 152 SER A 289 SITE 2 AC1 10 LEU A 293 GLY A 317 SER A 318 HOH A 548 SITE 3 AC1 10 HOH A 706 HOH A 714 CRYST1 76.652 69.776 62.818 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013046 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014332 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015919 0.00000